Results 11 to 20 of about 57,228 (301)
Mesenchymal stem cells: A novel treatment option for primary sclerosing cholangitis
Cell Biology International, Volume 47, Issue 2, Page 467-479, February 2023., 2023 Abstract Primary sclerosing cholangitis (PSC) is a progressive liver disease for which there is no effective therapy. Hepatocytes and cholangiocytes from a PSC patient were cocultured with mesenchymal stem cells (MSCs) to assess in vitro change. A single patient with progressive PSC was treated with 150 million MSCs via direct injection into the common
Amy L. Lightner +8 more
wiley +1 more source
Diagnostic Cytopathology, Volume 51, Issue 2, Page 117-122, February 2023., 2023 Abstract Background Primary sclerosing cholangitis (PSC) can present diagnostic difficulties on bile duct brushings as cytologic features mimicking adenocarcinoma may exist. This study evaluates the role of fluorescence in‐situ hybridization (FISH) as an adjunct to cytologic evaluation.
Suzanne M. Selvaggi
wiley +1 more source
Arquivos de Gastroenterologia, 2021 BACKGROUND: Endoscopic retrograde cholangiopancreatography is a widely used therapeutic modality for the pancreaticobiliary tree. However, it is responsible for the highest rates of complications among the endoscopic procedures, especially post ...
Loyna Flores PAEZ +4 more
doaj +1 more source
Digestive Endoscopy, 2021 The reported incidence of adverse events (AEs) in endoscopic retrograde cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study was to evaluate the incidence and severity of AEs in biliary ERCP and to specify the risk factors ...
K. Fujita +14 more
semanticscholar +1 more source
Diagnostic Cytopathology, Volume 51, Issue 1, Page 83-94, January 2023., 2023 Abstract Molecular diagnostics has expanded to become the standard of care for a variety of solid tumor types. With limited diagnostic material, it is often desirable to use cytological preparations to provide rapid and accurate molecular results. This review covers important pre‐analytic considerations and limitations, and a description of common ...
Scott A. Turner +2 more
wiley +1 more source
Einstein (São Paulo), 2020 Objective: To determine the period during which we should avoid cholecystectomy after endoscopic retrograde cholangiopancreatography. Methods: A retrospective analysis of electronic medical charts of 532 patients undergoing endoscopic retrograde ...
Murillo de Lima Favaro +5 more
doaj +2 more sources
Endoscopic retrograde cholangiopancreatography: Current practice and future research
World Journal of Gastrointestinal Endoscopy, 2021 Endoscopic retrograde cholangiopancreatography (ERCP) has evolved from a primarily diagnostic to therapeutic procedure in hepatobiliary and pancreatic disease.
David J. Sanders +3 more
semanticscholar +1 more source
Predisposing Factors in Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis [PDF]
, 2022 Objective: To ascertain the prevalence of risk factors in pancreatitis after endoscopic retrograde cholangiopancreatography at Isra University Hospital in Hyderabad.
Gotam Das +5 more
core +2 more sources
JGH Open, Volume 7, Issue 1, Page 16-23, January 2023., 2023 Endoscopic CBD stone removal is more difficult with stones larger than 2 mm than with distal CBD diameter or round or square‐shaped stones. Therefore, endoscopic large papillary balloon dilatation (ELPBD) is probably more required for stones larger than 2 mm than for distal CBD; likewise, round or square‐shaped stones are likely more required for ELPBD
Chote Wongkanong +4 more
wiley +1 more source
Role of circulating exosomal biomarkers and their diagnostic accuracy in pancreatic cancer
JGH Open, Volume 7, Issue 1, Page 30-39, January 2023., 2023 This systematic review aims to evaluate the current literature involving pancreatic cancer patient groups in search of highly accurate exosomal biomarkers. We reviewed 9 studies which involved 565 participants (331 PC and 234 controls). The mRNA panel (ARG1, CD63, CK18, Erbb3, GAPDH, H3F3A, KRAS, and ODC1) and GPC1 reported the highest performing ...
Menazir Sha +5 more
wiley +1 more source